Shattuck Labs (STTK) Share-based Compensation (2019 - 2026)
Shattuck Labs' (STTK) quarterly Share-based Compensation came in at $262000.0 in Q1 2026, down 84.78% year-on-year from $1.7 million in Q1 2025, and down 96.22% on a QoQ basis from $6.9 million in Q4 2025.
Shattuck Labs (STTK) Share-based Compensation (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Share-based Compensation data on file, last reported at $262000.0 in Q1 2026.
- On a quarterly basis, Share-based Compensation fell 84.78% year-over-year to $262000.0 in Q1 2026; TTM through Mar 2026 was $5.5 million, a 1927.06% increase from a year earlier, with the FY2025 full-year figure at $7.0 million, up 1451.0% from the prior year.
- Share-based Compensation for Q1 2026 stood at $262000.0, down from $6.9 million in the prior quarter.
- Over the last five years, Share-based Compensation for STTK reached as high as $7.2 million in Q3 2024 and fell as low as -$7.2 million in Q4 2024.
- Historically, Share-based Compensation has averaged $1.5 million across 5 years, with a median of $1.8 million in 2025.
- On a YoY basis, Share-based Compensation climbed as much as 6246.15% in 2024 and fell as far as 205.0% in 2024.
- Year by year, Share-based Compensation stood at $2.9 million in 2022, then jumped by 134.3% to $6.9 million in 2023, then tumbled by 205.0% to -$7.2 million in 2024, then surged by 195.65% to $6.9 million in 2025, then plunged by 96.22% to $262000.0 in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $262000.0 in Q1 2026, $6.9 million in Q4 2025, and -$3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | 262,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 262,000.00 |
| Mar 31, 2026 | 262,000.00 |
| Dec 31, 2025 | 6.93 Mn |
| Dec 31, 2025 | 6.93 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | -7.25 Mn |
| Dec 31, 2024 | -7.25 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Jun 30, 2024 | -2.03 Mn |
| Jun 30, 2024 | -2.03 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 6.90 Mn |
| Dec 31, 2023 | 6.90 Mn |